MicroRNA-27a Inhibits Trophoblast Cell Migration and Invasion by Targeting SMAD2: Potential Role in Preeclampsia
Overview
Authors
Affiliations
Preeclampsia (PE) is a severe idiopathic obstetric complication that occurs worldwide. Insufficient trophoblast invasion is a characteristic of the pathogenesis of PE. MicroRNA-27a (miR-27a) has been reported to be highly expressed in PE placentas. The aim of the present study was to investigate the role and underlying mechanisms of miR-27a in the pathogenesis of PE. The expression level of miR-27a was evaluated in the placenta and serum from patients with PE and healthy pregnant women. Cell Counting Kit-8 and flow cytometry assays were performed to detect human HTR-8/SVneo trophoblast proliferation and apoptosis after miR-27a overexpression or inhibition. In addition, Transwell assays were used to measure cell migration and invasion. A luciferase reporter assay was performed to determine the interaction between miR-27a and SMAD2. The present results suggested that miR-27a expression level was significantly increased in PE placentas and serum. In addition, miR-27a overexpression suppressed cell migratory and invasive abilities, impaired proliferation and promoted apoptosis in human trophoblasts. It was demonstrated that miR-27a may target SMAD and contribute to trophoblast invasion. Collectively, the results of the present study suggested that miR-27a inhibited trophoblast cell migration and invasion by targeting SMAD2, thus presenting a promising therapeutic target for PE.
Abel T, Moodley J, Khaliq O, Naicker T Int J Mol Sci. 2022; 23(22).
PMID: 36430232 PMC: 9691176. DOI: 10.3390/ijms232213752.
Micro-RNAs in Human Placenta: Tiny Molecules, Immense Power.
Jin M, Xu Q, Li J, Xu S, Tang C Molecules. 2022; 27(18).
PMID: 36144676 PMC: 9501247. DOI: 10.3390/molecules27185943.
A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia.
Bao S, Zhou T, Yan C, Bao J, Yang F, Chao S BMC Med. 2022; 20(1):303.
PMID: 36096786 PMC: 9469544. DOI: 10.1186/s12916-022-02495-x.
Cirkovic A, Stanisavljevic D, Milin-Lazovic J, Rajovic N, Pavlovic V, Milicevic O Front Bioeng Biotechnol. 2022; 9:782845.
PMID: 35004644 PMC: 8740308. DOI: 10.3389/fbioe.2021.782845.
Chen G, Chen L, Huang Y, Zhu X, Yu Y Bioengineered. 2021; 13(2):3620-3633.
PMID: 34699308 PMC: 8974051. DOI: 10.1080/21655979.2021.1997132.